Campus Access Only

All rights reserved. This publication is intended for use solely by faculty, students, and staff of University of the Pacific. No part of this publication may be reproduced, distributed, or transmitted in any form or by any means, now known or later developed, including but not limited to photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the author or the publisher.

Date of Award


Document Type

Thesis - Pacific Access Restricted

Degree Name

Master of Arts (M.A.)



First Advisor

Kenneth Beauchamp

First Committee Member

Gary Howells

Second Committee Member

William Kehoe

Third Committee Member

Robert Schorr


The efficacy of risperidone (Risperdal) for the treatment of 3 chronically aggressive children was evaluated using an open-label, multiple-baseline design in a private practice setting. Results of both parent and teacher ratings demonstrated a reduction in aggressive and delinquent behavior in 2 of 3 participants upon introduction of Risperdal, with the third responding in similar fashion upon final dose adjustment. Each participant reported no occurrences of side effects. These findings suggest that Risperdal was well tolerated, and may serve as a safe and effective treatment modality for this challenging population.




9780493159546 , 0493159541

To access this thesis/dissertation you must have a valid email address and log-in to Scholarly Commons.

Find in PacificSearch Find in ProQuest



If you are the author and would like to grant permission to make your work openly accessible, please email